Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Milestone Pharmaceuticals Inc (NASDAQ: MIST) was $2.41 for the day, down -18.31% from the previous closing price of $2.95. In other words, the price has decreased by -$18.31 from its previous closing price. On the day, 27.95 million shares were traded. MIST stock price reached its highest trading level at $3.06 during the session, while it also had its lowest trading level at $1.61.
Ratios:
Our analysis of MIST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.24 and its Current Ratio is at 8.24. In the meantime, Its Debt-to-Equity ratio is 2.79 whereas as Long-Term Debt/Eq ratio is at 2.77.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on September 11, 2025, initiated with a Overweight rating and assigned the stock a target price of $4.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $9.Rodman & Renshaw initiated its Buy rating on August 22, 2024, with a $9 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIST now has a Market Capitalization of 205258128 and an Enterprise Value of 219436272.
Stock Price History:
The Beta on a monthly basis for MIST is 0.41, which has changed by 0.6480447 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, MIST has reached a high of $2.96, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is 11.07%, while the 200-Day Moving Average is calculated to be 38.16%.
Shares Statistics:
MIST traded an average of 2.23M shares per day over the past three months and 4114360 shares per day over the past ten days. A total of 85.17M shares are outstanding, with a floating share count of 81.02M. Insiders hold about 4.89% of the company’s shares, while institutions hold 40.88% stake in the company. Shares short for MIST as of 1764288000 were 7389406 with a Short Ratio of 3.32, compared to 1761868800 on 4556371. Therefore, it implies a Short% of Shares Outstanding of 7389406 and a Short% of Float of 8.68.
Earnings Estimates
. The current rating of Milestone Pharmaceuticals Inc (MIST) is the result of assessments by 3.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.19 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.61 and -$0.81 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is -$0.98, with 3.0 analysts recommending between -$0.71 and -$1.33.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $17.53M in the next fiscal year. The high estimate is $56M and the low estimate is $2.4M.
